Haemophilia B with inhibitors

Clinical trials for Haemophilia B with inhibitors explained in plain language.

Never miss a new study

Get alerted when new Haemophilia B with inhibitors trials appear

Sign up with your email to follow new studies for Haemophilia B with inhibitors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New daily injection could cut bleeding in Tough-to-Treat hemophilia

Disease control Ongoing

This study tests a drug called concizumab, given as a daily shot under the skin, to prevent bleeding in people with hemophilia A or B who have inhibitors (antibodies that block standard treatment). About 134 participants either start concizumab right away or continue their usual …

Matched conditions: HAEMOPHILIA B WITH INHIBITORS

Phase 3 • Sponsor: Novo Nordisk A/S • Aim: Disease control

Last updated Sep 11, 2026 00:00 UTC

Haemophilia B with inhibitors

Get alerted when new Haemophilia B with inhibitors trials appear

New daily injection could cut bleeding in Tough-to-Treat hemophilia